Pieris Pharmaceuticals
(NASDAQ) PIRS
Pieris Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$41.72M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
PIRS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pieris Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
29
CEO
Stephen S. Yoder
Website
www.pieris.comHeadquarters
Boston, MA 02109, US
PIRS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-98%
Return on Capital
0%
Return on Assets
-70%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$0.00
EBITDA
$0.00
Operating Cash Flow
$25.01M
Capital Expenditure
$0.00
Free Cash Flow
$25.01M
Cash & ST Invst.
$57.98M
Total Debt
$633.00K
Pieris Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
+100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
46
N/A
Net Income
$12.71M
-109.6%
EBITDA
$9.84M
-22.2%
Quarterly Fundamentals
Net Cash
$57.35M
-31.4%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$431.00K
N/A
Short Term Debt
$202.00K
N/A
Return on Assets
-70.04%
N/A
Return on Invested Capital
0.00%
N/A
Free Cash Flow
$740.00K
+129.5%
Operating Cash Flow
$740.00K
+129.5%